Clinical-Grade Wearables: De-Risking Cardiac AI for VCs
The promise of value-based care (VBC) hinges on demonstrable outcomes and verifiable cost reductions. For investors eyeing the burgeoning cardiac AI market, distinguishing between platforms…
The promise of value-based care (VBC) hinges on demonstrable outcomes and verifiable cost reductions. For investors eyeing the burgeoning cardiac AI market, distinguishing between platforms…
The slow, uneven shift to value-based care is a mess, but it’s also creating some very specific opportunities. In this new world, platforms that can…
The promise of AI in healthcare always brings up futuristic ideas about diagnostics and personalized medicine. For investors, it boils down to something much simpler:…
The promise of AI in healthcare is vast, yet its true impact on value-based care (VBC) hinges not on ephemeral pilot results, but on demonstrable,…
The promise of artificial intelligence in healthcare is vast, yet for health plan executives and investors, the critical question remains: which AI applications deliver tangible,…
The promise of artificial intelligence in healthcare is vast, offering pathways to improved outcomes and significant cost reductions. However, for employers and health plan executives…
The promise of artificial intelligence in healthcare is vast, yet its integration into value-based care (VBC) models hinges on a singular, non-negotiable requirement: robust, peer-reviewed…
Self-insured employers and their human resources leaders face a critical juncture in managing healthcare costs: the promise of artificial intelligence (AI) to deliver efficiencies and…
The recent implosion of Pear Therapeutics, once a darling of the digital therapeutics (DTx) space, serves as a stark, cautionary tale for investors and health…
The burgeoning landscape of AI in healthcare presents a critical divide for health plans and employers: distinguishing between solutions genuinely poised for value-based care (VBC)…